News & Events

Publications

Health Affairs Forefront
Do Medicare’s IPAY 2027 Negotiated Drug Prices Reflect Value For Money?
Health Affairs Forefront
The ‘Pharm-To-Table’ Movement For Prescription Drugs: Promising Or Performative?
Medical Decision Making
When Do Published Cost-Effectiveness Analyses Include Societal Costs? An Empirical Analysis, 2013–2023
Health Affairs Scholar
The Unintended Consequences of the Inflation Reduction Act on Biosimilar Market Incentives and Medicare Savings
The Journal of Pediatrics
Rapid Genome Sequencing Compared with a Gene Panel in Critically Ill Infants with a Suspected Genetic Disorder: An Economic Evaluation
JAMA
Variation in US Commercial Health Plan Coverage Restrictions for Cell and Gene Therapies
Journal of Pain and Symptom Management
Bereavement Experiences Among Parents of Children With Spinal Muscular Atrophy Type 1
Vaccine
Family spillover effects in cost-effectiveness analyses of vaccines
Alzheimers & Dementia
Characterizing financial risk from out-of-pocket expenditures across dementia stages